Cargando…
Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease
AIMS: Maintenance of euvolaemia with diuretics is critical in heart failure (HF) patients with chronic kidney disease (CKD); however, it is challenging because no reliable marker of volume status exists. Fractional excretion of urea nitrogen (FEUN) is a useful index of volume status in patients with...
Autores principales: | Watanabe, Yukihiro, Kubota, Yoshiaki, Nishino, Takuya, Tara, Shuhei, Kato, Katsuhito, Hayashi, Daisuke, Mozawa, Kosuke, Matsuda, Junya, Tokita, Yukichi, Yasutake, Masahiro, Asai, Kuniya, Iwasaki, Yu‐ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192260/ https://www.ncbi.nlm.nih.gov/pubmed/36823779 http://dx.doi.org/10.1002/ehf2.14327 |
Ejemplares similares
-
Predictive Factors for Decreasing Left Ventricular Ejection Fraction and Progression to the Dilated Phase of Hypertrophic Cardiomyopathy
por: Ishihara, Kakeru, et al.
Publicado: (2023) -
Effect of Empagliflozin Versus Placebo on Plasma Volume Status in Patients with Acute Myocardial Infarction and Type 2 Diabetes Mellitus
por: Hoshika, Yu, et al.
Publicado: (2021) -
Empagliflozin confers reno‐protection in acute myocardial infarction and type 2 diabetes mellitus
por: Mozawa, Kosuke, et al.
Publicado: (2021) -
Impact of the COVID-19 Pandemic on ST-elevation Myocardial Infarction from a Single-center Experience in Tokyo
por: Watanabe, Yukihiro, et al.
Publicado: (2021) -
Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial
por: Shimizu, Wataru, et al.
Publicado: (2020)